Transactions

Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering

On May 16, 2016, Revive Therapeutics Ltd. (TSXV:  RVV) announced a best efforts rights offering to raise $2.2 million.  Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.

Back

Recent Transactions

11 November 2022

Peterson McVicar Acts for Euro Sun in $2.365 Million Private Placement

Learn More

29 September 2022

Peterson McVicar Acts for Red Cloud Securities Inc. in Brokered Private Placement with Grounded Lithium for up to C$5.0 Million

Learn More

02 September 2022

Peterson McVicar Acts for HIVE Blockchain in At-The-Market Equity Program

Learn More

25 August 2022

Peterson McVicar Acts for Red Cloud in Heritage Mining Ltd. Initial Public Offering

Learn More